» Articles » PMID: 26438524

UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity Via Control of Lytic Granule Secretion

Overview
Journal J Immunol
Date 2015 Oct 7
PMID 26438524
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

NK cell's killing is a tightly regulated process under the control of specific cytoskeletal proteins. This includes Wiskott-Aldrich syndrome protein, Wiskott-Aldrich syndrome protein-interacting protein, cofilin, Munc13-4, and nonmuscle myosin IIA (NMIIA). These proteins play a key role in controlling NK-mediated cytotoxicity either via regulating the attachment of lytic granules to the actin-based cytoskeleton or via promoting the cytoskeletal reorganization that is requisite for lytic granule release. UNC-45A is a highly conserved member of the UNC-45/CRO1/She4p family of proteins that act as chaperones for both conventional and nonconventional myosin. Although we and others have shown that in lower organisms and in mammalian cells NMIIA-associated functions, such as cytokinesis, cell motility, and organelle trafficking, are dependent upon the presence of UNC-45A, its role in NK-mediated functions is largely unknown. In this article, we describe UNC-45A as a key regulator of NK-mediated cell toxicity. Specifically we show that, in human NK cells, UNC-45A localize at the NK cell immunological synapse of activated NK cells and is part of the multiprotein complex formed during NK cell activation. Furthermore, we show that UNC-45A is disposable for NK cell immunological synapse formation and lytic granules reorientation but crucial for lytic granule exocytosis. Lastly, loss of UNC-45A leads to reduced NMIIA binding to actin, suggesting that UNC-45A is a crucial component in regulating human NK cell cytoskeletal dynamics via promoting the formation of actomyosin complexes.

Citing Articles

UNC-45A: A potential therapeutic target for malignant tumors.

Wang H, Sun F Heliyon. 2024; 10(10):e31276.

PMID: 38803956 PMC: 11128996. DOI: 10.1016/j.heliyon.2024.e31276.


Longitudinal proteomic investigation of COVID-19 vaccination.

Wang Y, Zhu Q, Sun R, Yi X, Huang L, Hu Y Protein Cell. 2023; 14(9):668-682.

PMID: 36930526 PMC: 10501184. DOI: 10.1093/procel/pwad004.


Locked and Loaded: Mechanisms Regulating Natural Killer Cell Lytic Granule Biogenesis and Release.

Ham H, Medlyn M, Billadeau D Front Immunol. 2022; 13:871106.

PMID: 35558071 PMC: 9088006. DOI: 10.3389/fimmu.2022.871106.


The Actin Regulators Involved in the Function and Related Diseases of Lymphocytes.

Sun J, Zhong X, Fu X, Miller H, Lee P, Yu B Front Immunol. 2022; 13:799309.

PMID: 35371070 PMC: 8965893. DOI: 10.3389/fimmu.2022.799309.


Ginsenoside Rg1 ameliorates blood-brain barrier disruption and traumatic brain injury attenuating macrophages derived exosomes miR-21 release.

Zhai K, Duan H, Wang W, Zhao S, Khan G, Wang M Acta Pharm Sin B. 2021; 11(11):3493-3507.

PMID: 34900532 PMC: 8642604. DOI: 10.1016/j.apsb.2021.03.032.


References
1.
Elstak E, Te Loo M, Tesselaar K, van Kerkhof P, Loeffen J, Grivas D . A novel Dutch mutation in UNC13D reveals an essential role of the C2B domain in munc13-4 function. Pediatr Blood Cancer. 2011; 58(4):598-605. DOI: 10.1002/pbc.23253. View

2.
Ramamurthy B, Yengo C, Straight A, Mitchison T, Sweeney H . Kinetic mechanism of blebbistatin inhibition of nonmuscle myosin IIb. Biochemistry. 2004; 43(46):14832-9. DOI: 10.1021/bi0490284. View

3.
Ramesh N, Anton I, Hartwig J, Geha R . WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc Natl Acad Sci U S A. 1998; 94(26):14671-6. PMC: 25088. DOI: 10.1073/pnas.94.26.14671. View

4.
Barral J, Hutagalung A, Brinker A, Hartl F, Epstein H . Role of the myosin assembly protein UNC-45 as a molecular chaperone for myosin. Science. 2002; 295(5555):669-71. DOI: 10.1126/science.1066648. View

5.
Andzelm M, Chen X, Krzewski K, Orange J, Strominger J . Myosin IIA is required for cytolytic granule exocytosis in human NK cells. J Exp Med. 2007; 204(10):2285-91. PMC: 2118468. DOI: 10.1084/jem.20071143. View